2 completed, 1 recruiting, 1 suspended. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Suspended 1 |
Follow Transformed Mycosis Fungoides: new trials by email Literature Review of Transformed Mycosis Fungoides trials Research Report on Transformed Mycosis Fungoides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies WU-CART-007 - T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia | Phase 1 | Suspended | Washington University School of Medicine | 6 | 2023-10-10 | 2026-07-21 |
| Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma Extracorporeal Photopheresis, Mogamulizumab, Quality-of-Life Assessment - Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Phase 2 | Recruiting | City of Hope Medical Center | 34 | 2022-10-19 | 2026-09-02 |
| Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides AFM13 - Peripheral T Cell Lymphoma, Transformed Mycosis Fungoides | Phase 2 | Completed | Affimed GmbH | 108 | 2019-11-13 | 2024-11-05 |
| Mechlorethamine Induced Contact Dermatitis Avoidance Study Triamcinolone, Valchlor 0.016 % Topical Gel - Cutaneous T-cell Lymphoma, Cutaneous T-cell Lymphoma Stage I | Phase 2 | Completed | Rochester Skin Lymphoma Medical Group, PLLC | 28 | 2017-12-13 | 2026-09-04 |
Lymphoma, T-Cell, Cutaneous (2) · Lymphoma, T-Cell, Peripheral (2) · Mycosis Fungoides (2) · Sezary Syndrome (2) · Dermatitis, Contact (1) · Enteropathy-Associated T-Cell Lymphoma (1) · Immunoblastic Lymphadenopathy (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Prolymphocytic, T-Cell (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma (4) · Lymphoma, Non-Hodgkin (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Lymphoma, T-Cell (3) · Dermatitis (1) · Hematologic Diseases (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid (1)
AFM13 (1) · Amines (1) · Disulfides (1) · Gels (1) · Immunoglobulin G (1) · Mechlorethamine (1) · Ointments (1) · Photopheresis (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · mogamulizumab (1)
Affimed GmbH (1) · City of Hope Medical Center (1) · Rochester Skin Lymphoma Medical Group, PLLC (1) · Washington University School of Medicine (1)
United States (4) · Australia (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Turkey (Türkiye) (1)
Brian Poligone, MD, PhD (1) · Christiane R Querfeld (1) · Geoffrey Uy, M.D. (1) · Karenza Alexis, MD (1) · Steven Horwitz, MD (1) · Won Seog Kim, Dr (1)
P30CA033572 (1)